Home LiteratureArticle Details
PMID: 2474543 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells.

The Journal of biological chemistry ·Vol. 264 ·No. 24 ·1989-08-25 ·Pages 14305-11

Faltynek CR, Princler GL, Gusella GL, Varesio L, Radzioch D

Abstract

Treatment of Daudi B lymphoblastoid cells with interferon (IFN)-alpha or -beta has been reported (Yap, W. H., Teo, T. S., and Tan, Y. H. (1986) Science 234, 355-358) to cause a transient increase in the level of diacylglycerol, which is the endogenous activator of protein kinase C (PK-C). To assess the role for PK-C in the induction of 2-5A synthetase mRNA and activity by IFN-alpha in Daudi cells, we have examined the effects of PK-C inhibitors and activators. We have found that the PK-C inhibitor, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), strongly inhibits the induction of 2-5A synthetase mRNA and activity by recombinant IFN-alpha A (rIFN-alpha A) and that this inhibition appears to be at a post-transcriptional level. The inhibition by H7 could not be attributed to a generalized decrease in macromolecular synthesis or to inhibition of the binding or internalization of rIFN-alpha A. Moreover, pretreatment of Daudi cells for 24 h with phorbol esters to down-regulate or desensitize PK-C substantially inhibited the subsequent induction of 2-5A synthetase mRNA and activity by rIFN-alpha A. These data suggest that PK-C activity is required for the induction of 2-5A synthetase by rIFN-alpha A. However, phorbol esters, which are potent PK-C activators, did not induce 2-5A synthetase. Taken together, our data indicate that a functional PK-C is required for 2-5A synthetase induction by rIFN-alpha A at a post-transcriptional level in Daudi cells but that activation of PK-C is not sufficient for induction of this enzyme.

MeSH Terms
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine 2',5'-Oligoadenylate Synthetase/biosynthesis,genetics Cell Line Endocytosis/drug effects Humans Interferon Type I/metabolism,pharmacology Isoquinolines/pharmacology Phorbol Esters/pharmacology Piperazines/pharmacology Protein Biosynthesis Protein Kinase C/antagonists & inhibitors,physiology RNA/biosynthesis RNA, Messenger/biosynthesis Recombinant Proteins Sulfonamides Transcription, Genetic Tumor Cells, Cultured/drug effects,enzymology
Chemicals
Interferon Type I Isoquinolines Phorbol Esters Piperazines RNA, Messenger Recombinant Proteins Sulfonamides RNA 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine N-(2-guanidinoethyl)-5-isoquinolinesulfonamide Protein Kinase C 2',5'-Oligoadenylate Synthetase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Faltynek C R
Biological Carcinogenesis and Development Program, National Cancer Institute, Frederick, Maryland 21701.
Princler G L
Gusella G L
Varesio L
Radzioch D
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1989-08-25
Pages
14305-11
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NCI NIH HHS · N01-CO-74102 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com